Dr. Fazle Kibria | Biomaterials | Best Researcher Award

Published on 04/11/2025 by Material Scientist

Dr. Fazle Kibria | Biomaterials | Best Researcher Award

Lovelace Biomedical Research Institute | United States

Dr. Fazle Kibria is a highly skilled biomedical engineer and postdoctoral scholar at the Lovelace Biomedical Research Institute, USA, specializing in photonics-based neuromodulation and implantable device design for traumatic brain injury treatment. With a Ph.D. in Biomedical Engineering from Jadavpur University, he has established himself as a promising researcher in neuroengineering, optical fiber sensors, and biomedical device innovation. Dr. Kibria has authored 4 scientific papers, attracting 16 citations from 16 documents, and holds an h-index of 2, reflecting the growing impact of his research in the fields of photobiomodulation, neurotherapy, and medical device development. His professional experience spans prestigious institutions such as the University of South Florida, Case Western Reserve University, and the Department of Health & Family Welfare, Government of West Bengal, India, where he contributed to medical technology implementation and healthcare infrastructure. His research focuses on developing advanced optical fiber probes, polymer-based biosensors, and piezoelectric nanofiber devices for non-invasive diagnostics and neurocardiac analysis. He has received the Gandhian Young Technological Innovation Award, among others, for his pioneering work in fabricating nano-probes and biomedical sensors. A member of SPIE, the American Heart Association, and the Indian Science Congress Association, Dr. Kibria is committed to merging engineering and medicine to develop next-generation biomedical technologies for brain and cardiac health, contributing meaningfully to the global medical research community.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Cáceres, F. K. A. A. D. E., Salazar, P., Shidoh, S., Ortiz, M. J., & Denis, E. (2025). Noninvasive vagus nerve stimulation protects neurons in the perihematomal region and improves the outcomes in a rat model of intracerebral hemorrhage. Neurocritical Care, 4.

Patra, F. K. S. N. (2018). Fabrication of fiber-aided nano device for minimally invasive photonics-based sub-micron level lesion detection and interventional treatment. International Journal for Research in Engineering Application & Management, 2.

Kibria, F. A. O. T. D. B., & Bragina, O. A. (2025). Bidirectional interplay between traumatic brain injury and cardiovascular dysfunction in athletes. Journal of Clinical Medicine, 14(21), 7712.

Bragin, D., Kibria, F., Bragina, O., Trofimov, A., Kalinkina, E., Volkova, E., et al. (2025). Photobiomodulation in the treatment of acute traumatic brain injury. Critical Care Medicine, 53(1).

Kibria, F., Das, S. K., & Arefin, M. S. (2024). The role of nicotinamide adenine dinucleotide salvage enzymes in cardioprotection. Polish Journal of Thoracic and Cardiovascular Surgery, 21(2), 86–95.

Dr. DuJiang Yang | Biomaterials | Best Researcher Award

Published on 03/11/2025 by Material Scientist

Dr. DuJiang Yang | Biomaterials | Best Researcher Award

The Affiliated Traditional Chinese Medicine Hospital | Southwest Medical University | China

Dr. DuJiang Yang is an emerging medical researcher and clinician specializing in traditional Chinese orthopedics, with a strong focus on molecular mechanisms of bone and joint disorders. Currently pursuing his master’s degree in Orthopedic Traditional Chinese Medicine at Southwest Medical University, Dr. Yang has already established an impressive research record for his age. He has published 13 SCI-indexed papers as the first author, with an h-index of 1, 13 total publications, and 3 citations recorded across 3 cited documents. His research spans areas including osteoarthritis, spinal cord injury, and immunopathology, with multiple contributions in prestigious journals such as Leukemia, Angiogenesis, Biofabrication, Journal of Translational Medicine, and Diabetes/Metabolism Research and Reviews. His cumulative impact factor exceeds 120, reflecting the international recognition of his scientific quality. Dr. Yang’s studies often bridge traditional medicine and advanced biomedical technologies such as single-cell analysis, spatial transcriptomics, and molecular docking, aiming to decode therapeutic mechanisms of herbal formulations in musculoskeletal regeneration. In addition to research, he actively participates in clinical training at the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, where he applies his translational insights to patient care. His early achievements have earned him numerous awards, including multiple “Excellent Student” and “Outstanding Youth” recognitions, highlighting his leadership and scholarly promise. Technically proficient in molecular biology methods and statistical software, Dr. Yang demonstrates exceptional capability in both bench and clinical research environments. With an expanding international publication record, he stands as a young yet influential voice in translational orthopedics, committed to advancing evidence-based approaches that integrate traditional medicine with modern molecular science.

Profile: Scopus

Featured Publications

Yang, D. J., Gong, G. W., Song, J. F., Li, J. C., Chen, J. J., & Wang, G. Y. (2025). Ferroptosis-mediated osteoclast–osteoblast crosstalk: Signaling pathways governing bone remodeling in osteoporosis. Journal of Orthopaedic Surgery and Research, [Q3, IF = 2.8].

Yang, D. J., Liu, Q., Tang, X. X., Chen, J., Wang, S., Gong, G., & Wang, G. Y. (2025). Letter to the editor regarding: Bio-3D printing of scaffold-free ADSC-derived cartilage constructs comparable to natural cartilage in vitro. Journal of Orthopaedic Surgery and Research, [Q3, IF = 2.8].

Lu, J., Yang, D. J., Lai, C., & Wang, G. Y. (2025). Letter to the editor regarding: SIRT3 alleviates mitochondrial dysfunction and senescence in diabetes-associated periodontitis by deacetylating LRPPRC. Aging and Disease, [Q2, IF = 6.9].

Chen, J. J., Yang, D. J., He, J. Y., Yuan, X. T., Liu, Y. Q., Yang, J. X., Wang, G. Y., Peng, T., & Shen, H. R. (2025). Polygonatum polysaccharide induces tenocyte stem cell differentiation into chondrocytes through the TGF-β3/SMAD2 signaling pathway. Chinese Journal of Clinical Pharmacology and Therapeutics, 30(7), 1010. [Peking University Core Journal].

Yang, W., Ma, G., Li, J., Guan, T., He, D., Yang, D., Wang, G., & Shi, H. (2025). Anxiety and depression as potential risk factors for limited pain management in elderly patients with knee osteoarthritis: A cross-lagged study. [Journal Name] [SCI Q2, IF = 3.3].

Prof. Dr. Zine El Abidine Chaoui | Biomaterials | Best Researcher Award

Published on 31/10/2025 by Material Scientist

Prof. Dr. Zine El Abidine Chaoui | Biomaterials | Best Researcher Award

Setif 1 University Ferhat Abbas | Algeria

Prof. Dr. Zine El Abidine Chaoui is a distinguished physicist and academic leader serving at the University of Setif 1, Algeria, where he holds a permanent position in the Department of Physics. With an exceptional academic and research career spanning over two decades, he has made significant contributions to radiation physics, dosimetry, radiotherapy, and radiobiology. He currently leads the Optoelectronics and Devices Laboratory and coordinates the Medical Physics Master’s program, where he also oversees a high-performance computing platform for advanced simulation research. Prof. Chaoui has authored 26 peer-reviewed publications, accumulated 321 citations from 243 documents, and holds an h-index of 10, reflecting the lasting impact of his scientific work. His research includes groundbreaking studies on Monte Carlo simulations for radiation transport, radiobiological modeling for treatment optimization, and dosimetric evaluations of cancer therapy techniques such as IMRT and VMAT. His articles have appeared in leading international journals including Applied Radiation and Isotopes, Journal of Instrumentation, Surface and Interface Analysis, and Physics Letters A. Beyond his research, Prof. Chaoui has supervised numerous Ph.D. and Master’s theses, fostering the next generation of medical physicists in Algeria. His international collaborations span esteemed institutions such as the University of Trento, University of Birmingham, Swansea University, and PTB Braunschweig, enhancing his global research footprint. A recognized expert in radiation physics education and research, Prof. Chaoui has contributed extensively to improving radiotherapy accuracy and safety. His pioneering efforts in simulation and radiobiology continue to influence modern cancer treatment methodologies. Through his scientific rigor, mentorship, and leadership, Prof. Dr. Zine El Abidine Chaoui exemplifies excellence in the fields of radiation physics and medical dosimetry.

Profiles: Orcid | Scopus

Featured Publications

Chaoui, Z.-E.-A. (2025). New radiobiological comparison of intensity-modulated radiation therapy prostate plans of seven and five fields. International Journal of Radiation Research.

Chaoui, Z.-E.-A. (2022). Dosimetric beam matching analysis of MV photons and electrons therapy. International Journal of Radiation Research, 20(3), 25–35.

Chaoui, Z.-E.-A. (2021). PENELOPE simulations and experiment for 6 MV Clinac iX accelerator for standard and small static fields. Applied Radiation and Isotopes, 178, 109749.

Aker, M., Altenmüller, K., Amsbaugh, J. F., Arenz, M., Babutzka, M., Bast, J., Bauer, S., Bechtler, H., Beck, M., Beglarian, A., et al. (2021). The design, construction, and commissioning of the KATRIN experiment. Journal of Instrumentation, 16(08), T08015.

Aouina, N. Y., & Chaoui, Z.-E.-A. (2018). Electrons and positrons elastic collisions with pyrimidine and tetrahydrofuran. Applied Radiation and Isotopes, 140, 197–203.

Mr. Kunal Pal | Biomaterials | Young Scientist Award

Published on 07/10/202507/10/2025 by Material Scientist

Mr. Kunal Pal | Biomaterials | Young Scientist Award

Mr. Kunal Pal | Jadavpur University | India

Mr. Kunal Pal is an emerging biomedical researcher with strong expertise in nanomedicine, molecular biology, and cancer therapeutics. With 64 published documents, 1,326 total citations from 1,177 referencing documents, and an h-index of 20, his research contributions reflect high academic quality and influence. He has conducted pioneering work in developing nanoparticle-based delivery systems, particularly focusing on biocompatible and green nanomaterials for targeted cancer therapy. His doctoral research at Bose Institute explored curcumin delivery systems for triple-negative breast cancer, showcasing innovation in molecular design and therapeutic efficacy. Mr. Pal’s studies integrate multidisciplinary approaches encompassing toxicology, bioimaging, nanotechnology, and drug delivery mechanisms, resulting in publications in reputed journals such as Inorganic Chemistry, Dalton Transactions, Materials Science and Engineering: C, and Nanomedicine. He has also presented his research at multiple international conferences and received honors including the Young Researcher Award from the National Environmental Science Academy. Beyond academia, he has served as a scientific advisor in industry and reviewer for leading journals like Scientific Reports and Apoptosis, demonstrating his versatility and leadership in translational science. His commitment to bridging molecular research with therapeutic applications positions him as a forward-looking scientist contributing to the advancement of biomedical innovation and sustainable nanotechnology in cancer treatment.

Profiles: Scopus | Google Scholar

Featured Publications

Gautam, A., Ray, A., Mukherjee, S., Das, S., Pal, K., Das, S., Karmakar, P., Ray, M., et al. (2018). Immunotoxicity of copper nanoparticle and copper sulfate in a common Indian earthworm. Ecotoxicology and Environmental Safety, 148, 620–631.

Laha, D., Pal, K., Chowdhuri, A. R., Parida, P. K., Sahu, S. K., Jana, K., & Karmakar, P. (2019). Fabrication of curcumin-loaded folic acid-tagged metal-organic framework for triple negative breast cancer therapy in in vitro and in vivo systems. New Journal of Chemistry, 43(1), 217–229.

Roy, S. D. S., Bardhan, S., Pal, K., Ghosh, S., Mandal, P., et al. (2018). Crystallinity mediated variation in optical and electrical properties of hydrothermally synthesized boehmite (γ-AlOOH) nanoparticles. Journal of Alloys and Compounds, 763, 749–758.

Banerjee, S., Bagchi, B., Bhandary, S., Kool, A., Hoque, N. A., Biswas, P., Pal, K., et al. (2018). Antimicrobial and biocompatible fluorescent hydroxyapatite-chitosan nanocomposite films for biomedical applications. Colloids and Surfaces B: Biointerfaces, 171, 300–307.

Ghorai, P., Pal, K., Karmakar, P., & Saha, A. (2020). The development of two fluorescent chemosensors for the selective detection of Zn²⁺ and Al³⁺ ions in a quinoline platform by tuning the substituents in the receptor part. Dalton Transactions, 49(15), 4758–4773.

Assoc. Prof. Dr. Suray Pehlivanoglu | Biomaterials | Best Researcher Award

Published on 24/09/2025 by Material Scientist

Assoc. Prof. Dr. Suray Pehlivanoglu | Biomaterials | Best Researcher Award

Assoc. Prof. Dr. Suray Pehlivanoglu | Necmettin Erbakan University | Turkey

Assoc. Prof. Dr. Suray Pehlivanoğlu is a distinguished molecular biologist and geneticist serving at Necmettin Erbakan University, Faculty of Science, Department of Molecular Biology and Genetics, Meram, Konya, Turkey. He holds a Ph.D. in Medical Genetics from Akdeniz University, where his doctoral work focused on TWIST1 transcription factor activation mechanisms and natural inhibitors, building upon his earlier master’s research on FGFR2 gene mutations in craniosynostosis. Dr. Pehlivanoğlu’s academic career spans over a decade, progressing from Research Assistant at Akdeniz University to Assistant Professor and now Associate Professor, where he supervises master’s and doctoral theses in cancer biology, immunogenetics, and molecular signaling. His research emphasizes cancer molecular biology, transcription factor regulation, hypoxia signaling, PAK4-mediated pathways, nanoparticle-based therapeutics, and regenerative medicine, with contributions to the development of novel anticancer agents and nanomaterials with targeted cytotoxic effects. He has been principal investigator and collaborator on numerous nationally funded projects, including studies on platelet-derived growth factor signaling, TWIST1 target gene transcriptomics, and biosynthesis of anticancer nanomaterials. Dr. Pehlivanoğlu has authored 35 peer-reviewed documents, accumulating 254 citations from 243 publications and maintaining an h-index of 10, reflecting the impact and consistency of his scientific contributions. He has published widely in international journals such as Molecular and Cellular Endocrinology, Journal of Cellular and Molecular Medicine, and 3 Biotech, and contributed chapters to scientific books on neuroplasticity, craniosynostosis, and stem cell applications. His innovative work has earned several honors, including oral presentation awards and recognition for excellence in cancer biology research. Actively engaged in mentoring young researchers, he continues to explore molecular mechanisms of tumor progression, hypoxia response, and immune modulation, aiming to translate his findings into novel therapeutic strategies and clinical applications.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Sarigüney, B., Karakaş Sarikaya, E., & Pehlivanoğlu, S. (2024). Determining stable structure and in vitro antiproliferative properties of a novel 3-(2-((4-trifluoromethyl)phenyl)amino)thiazol-4-yl)-2H-chromen-2-one molecule. Chemistry & Biodiversity.

Acar, C. A., Gencer, M. A., Pehlivanoglu, S., Yesilot, S., & Donmez, S. (2024). Green and eco-friendly biosynthesis of zinc oxide nanoparticles using Calendula officinalis flower extract: Wound healing potential and antioxidant activity. International Wound Journal.

Acar, C. A., Pehlivanoglu, S., Yesilot, S., & Yakut Uzuner, S. (2023). Microwave-assisted biofabrication of silver nanoparticles using Helichrysum arenarium flower extract: Characterization and biomedical applications. Biomass Conversion and Biorefinery.

Findik, M., Türkkan, E., Pehlivanoglu, S., Sayin, U., Ceylan, U., & Akgemci, E. G. (2023). New copper(II) complex based-thiosemicarbazone and phenanthroline: DNA/BSA binding, antiproliferative activity, DFT and docking studies. Inorganic Chemistry Communications, 154, 111300.

Findik, M., Kuzu, B., Pehlivanoglu, S., Kaya, S., Sayin, U., Guler Akgemci, E., & Saf, A. O. (2023). Synthesis of carbazole-substituted thiosemicarbazone and its Cu(II) complex, DNA/protein binding, cytotoxic, antiproliferative activities and molecular docking studies. Inorganic Chemistry Communications, 152, 110711.

Dr. Baozhe Jin | Biomaterials | Best Researcher Award

Published on 06/08/202506/08/2025 by Material Scientist

Dr. Baozhe Jin | Biomaterials | Best Researcher Award

Dr. Baozhe Jin is a highly respected Chief Physician of Neurosurgery at The First Affiliated Hospital of Xinxiang Medical University, China. He is dedicated to advancing both clinical and basic research in neural injury, protection, and functional repair. With extensive experience in skull base microanatomy and nerve regeneration medicine, he contributes to critical breakthroughs in neurotrauma management. His ongoing projects focus on gene-modified therapies and neuroprotective strategies, highlighting his deep commitment to improving patient outcomes through innovation.

Dr. Baozhe Jin | The First Affiliated Hospital of Xinxiang Medical University | China

Profile

SCOPUS

Education

Dr. Jin possesses a robust medical and academic background, leading him to become a chief physician and researcher in the specialized field of neurofunctional repair. Though the exact educational milestones are not detailed, his clinical authority and ongoing research roles reflect a rigorous and accomplished academic journey. He actively collaborates with leading neurosurgery centers such as Beijing Tiantan Hospital and serves as a member of the Neurocontrol Professional Committee of the Chinese Medical Doctor Association, reinforcing his scientific credibility.

Experience

Dr. Jin has led major neuroprotective research initiatives, notably the Henan Medical Science and Technology Key Project investigating valproic acid combined with NT-3 gene-modified olfactory sheath cells for treating traumatic brain injury. This study blends clinical insight with cutting-edge biomedical engineering. Additionally, he participates in key scientific and technological research projects sponsored by Henan Province, focusing on improving post-injury neural outcomes.

Contributions

Dr. Baozhe Jin has demonstrated long-term dedication to advancing neural function repair and protection following traumatic brain injury (TBI). His research bridges skull base microanatomy, clinical neurosurgical applications, and regenerative neuroscience, focusing on developing innovative treatments such as gene-modified olfactory ensheathing cells and neuroprotective compounds. He combines clinical expertise with cutting-edge biomedical research to improve outcomes in patients with central nervous system injuries. His work contributes to the growing field of nerve regeneration medicine, making strides in both basic science and translational clinical applications

Research Focus

Dr. Jin’s research targets functional protection and repair following central nervous system injuries, including traumatic brain injury and spinal cord damage. His interdisciplinary approach bridges clinical neurosurgery, molecular neuropharmacology, and regenerative medicine, focusing on gene therapies, olfactory ensheathing cells, and pharmaceutical interventions like valproic acid. His contributions improve both the understanding and treatment of neural trauma.

Publications

Effect of Dynamin-2 Gene Modified OECs on Functional and Molecular Neuroprotection After Spinal Cord Injury in Rats
Journal: Neurochemical Research, 2025

Expression of Homeobox Gene-A7 in Glioma and Its Effect on Proliferation and Apoptosis of Glioma Cells
Journal: Journal of Xinxiang Medical University, 2024

Effect of Valproic Acid Combined with Transplantation of Olfactory Ensheathing Cells Modified by Neurotrophic 3 Gene on Nerve Protection and Repair After Traumatic Brain Injury
Journal: Neuropeptides, 2024

Conclusion

Dr. Baozhe Jin is a dedicated clinician-scientist with impactful research contributions in neural repair and regeneration. His work bridges basic neuroscience with clinical application, reflecting a strong foundation for innovation in the treatment of brain injuries. He is a deserving candidate for the Best Researcher Award, and with expanded academic outreach and global engagement, his influence in the field is likely to grow further.

Prof. Dr Jiang Chao | Biomaterials | Best Researcher Award

Published on 02/07/2025 by Material Scientist

Prof. Dr Jiang Chao | Biomaterials | Best Researcher Award

Dr. Jiang Chao 🎓🧠 is a leading neurologist and researcher at the Second Affiliated Hospital of Xi’an Medical University, specializing in integrative medicine, cerebrovascular diseases, and neuro-AI. With a Ph.D. from Shanghai University of Traditional Chinese Medicine, he has published over 90 scientific papers 📚, including 33 SCI-indexed articles 🌐. His innovations span AI-driven diagnostics, ALS interventions, and electroacupuncture therapies ⚙️🧪. Holder of 8 patents and author of 6 medical books, he also plays pivotal roles in 40+ medical associations 🏅. Dr. Jiang is shaping the future of clinical neuroscience and integrative neurology worldwide. 🌍💡

Prof. Dr jiang chao, The Second Affiliated Hospital of Xi ‘an Medical University, China

Profile

ORCID

🎓 Education

Dr. Jiang Chao earned his Ph.D. in Integrative Medicine (Neurology) from Shanghai University of Traditional Chinese Medicine in 2014. Currently, he serves as Director of Neurology at the Second Affiliated Hospital of Xi’an Medical University and Adjunct Professor at Northwestern University School of Medicine, Xi’an 🇨🇳. He is also the Honorary Director of the Tuberculosis Meningitis Department at Shaanxi Province’s Fifth Hospital 🏥. His academic journey is enriched by over 70 high-impact publications 📚 and a commitment to advancing medical education, with expertise spanning AI in neurology, stroke management, and clinical innovation 🔬💡.

🏥 Experience

Dr. Chao Jiang 🧠🎓 is currently the Director of Neurology at the Second Affiliated Hospital of Xi’an Medical University (2018–present) 🏥, where he leads advancements in cerebrovascular and neurological care. He also serves as Honorary Director (Tuberculosis Meningitis Specialist) at the Fifth Hospital of Shaanxi Province 🧬 and Adjunct Professor at Northwestern University School of Medicine, Xi’an 🎓. Previously, he completed a Postdoctoral Fellowship at Longhua Hospital, Shanghai University of Traditional Chinese Medicine (2019–2022), focusing on emergency neurology 🚨. His multidisciplinary experience bridges clinical neurology, AI applications, and integrative therapies, making him a pioneer in translational brain health research. 💡🧪

🧬 Contributions

Dr. Jiang Chao’s research investigates the therapeutic potential of early electroacupuncture (EA) on amyotrophic lateral sclerosis (ALS) by targeting the HMGB1/TLR4 signaling pathway 🔬🧬. The study aims to assess how EA modulates related protein expression and preserves oligodendrocyte integrity, ultimately improving motor function in ALS-affected mice 🦴🏃‍♂️. This innovative work integrates molecular neurobiology with traditional Chinese medicine, offering promising insights into non-pharmacological intervention for neurodegeneration. Dr. Jiang’s findings contribute significantly to neuroinflammation regulation, opening new doors for ALS treatment using integrative approaches. 🌿🧪💡

🔬 Research Focus

Prof. Dr. Jiang Chao’s research lies at the intersection of neurology and integrated traditional Chinese and Western medicine 🧬🌿. His work explores innovative, evidence-based approaches to treating neurological disorders such as stroke, Parkinson’s disease, and Alzheimer’s through synergistic therapies combining modern neuroscience 🧠 and classical Chinese herbal and acupuncture practices 🪷💉. He aims to enhance clinical outcomes, reduce side effects, and personalize treatment through integrative protocols. His research contributes to bridging the gap between ancient healing wisdom and cutting-edge biomedical science, promoting a holistic and effective model for neurological care and brain health 🩺🌐.

📚 Publication

[Retracted] Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma
Authors: Xu Chao, Wei Zhang, Jieqiong Wu, Xuesong Feng, Hailong Shi, Luyan Zhao, Haiyu Shen, Chao Jiang, Qian Wang
Journal: BioMed Research International (2021)

Effects of Electroacupuncture on the HMGB1/TLR4 Pathway and Oligodendrocytes in the Cerebral Cortex of Mice with Amyotrophic Lateral Sclerosis
Authors: Jiawei Zeng, Weijia Zhao, Junyang Liu, Shanshan Liu, Le Li, Weixing Feng, Yingqian Zhao, Qiang Wang, Chao Jiang
Journal: Journal of Acupuncture and Tuina Science (2025)

Prof. Dr Hein Van Poppel | Biomaterials | Best Researcher Award

Published on 21/06/202521/06/2025 by Material Scientist

Prof. Dr Hein Van Poppel | Biomaterials | Best Researcher Award

Prof. Dr. Hein Van Poppel 🇧🇪 is an internationally renowned urologist and oncologist 👨‍⚕️🔬 with over four decades of experience in prostate, bladder, and kidney cancer surgery 🎯🧬. As Full Professor at KU Leuven and former Director of Education at the European School of Urology 📘🏥, he has mentored thousands and performed 3,000+ prostatectomies. Author of over 500 scientific publications 📚✍️ and recipient of multiple lifetime achievement awards 🏆, he has revolutionized urologic care with innovations like the “N” pouch. His commitment to research, education, and patient advocacy makes him a global leader in medical science 🌍💡.

Prof. Dr Hein Van Poppel, EAU and KU Leuven, Belgium

Profile

ORCID

🎓 Education

Prof. Dr. Hein Van Poppel 🎓 is a leading figure in urology, earning his MD in General Surgery (1980) and Urology (1983), followed by a Ph.D. in Medical Sciences in 1988 🧠📘. He completed postgraduate training in major European centers including London, Barcelona, Copenhagen, Mainz, and Rotterdam 🌍🔬. In 1992, he became a Fellow of the European Board of Urology (FEBU) 🏅. Appointed Full Professor at KU Leuven in 1993 and Department Chair by 2002, his academic path laid the foundation for a distinguished global career in urologic oncology and medical education 🧪🏥.

👨‍⚕️ Experience

Prof. Dr. Hein Van Poppel is a world-renowned urologist 👨‍⚕️ with over 40 years of experience in uro-oncology, academic leadership, and surgical innovation 🔬✂️. Former Chair of Urology at KU Leuven 🏥, he pioneered techniques like the “N” pouch and prepubic urethrectomy. He served as Adjunct Secretary General of the EAU and Director of the European School of Urology 📘🇪🇺. With 3,000+ radical prostatectomies, 35+ doctoral mentorships 🎓, and 1,000+ global lectures 🌍🎤, he has significantly shaped prostate cancer care, surgical education, and health policy through EU initiatives like PRAISE-U 🧠🏛️.

🏆 Awards, Leadership & Impact

Prof. Van Poppel has received prestigious awards including the Folke Edsmyr Award (🇸🇪1999), Pieter De Mulder Award (🇫🇷2015), Francisco Diaz Medal (🇪🇸2015), SIU Distinguished Career Award (🇦🇷2016), and the Frans Debruyne Lifetime Achievement Award (2021) 🏅. In 2024–2025, he earned the Klaus-Meier Award, Laurent Boccon-Gibod Award, and the Wil de Jongh Medal 🏆. As EAU Adjunct Secretary General, he established the Patient Office 🧑‍⚕️🗣️, Policy Office 🏛️, and now coordinates PRAISE-U, an EU-funded initiative shaping the future of prostate cancer screening in Europe 🇪🇺📊. His leadership bridges research, advocacy, and public health innovation 🌍🔬.

🧬 Research Focus

Prof. Van Poppel’s research focuses on prostate, bladder, kidney, and testicular cancers 🔬🧬, with a strong emphasis on early detection, screening policies, and surgical oncology. He has led major studies on PSA testing, PRAISE-U early detection programs, and neoadjuvant therapies for high-risk prostate cancer 🧪💉. His work addresses public health impact, patient outcomes, and inequalities in urological cancer care across Europe 🌍🏥. With groundbreaking contributions in clinical trials, surgical techniques, and policy advocacy 📈📜, his research bridges clinical excellence and health equity—paving the way for smarter, earlier, and more effective cancer interventions 🚀🎯.

📘 Publications

Title: SIU-ICUD: Screening and Early Detection of Prostate Cancer
Contributors: Ola Bratt, Mohamed Jalloh, Anwar R. Padhani, Paul F. Pinsky, Hein Van Poppel, Weranja Ranasinghe, Kamran Zargar-Shoshtari, Kai Zhang, Anssi Auvinen
Journal: Société Internationale d’Urologie Journal (2025)

Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey
Contributors: Katharina Beyer, Renée C. A. Leenen, Lionne D. F. Venderbos, Jozien Helleman, Sebastiaan Remmers, Vera Vasilyeva, Juan Gómez Rivas, Erik Briers, Thomas Frese, Josep Vilaseca et al.
Journal: Journal of Personalized Medicine (2024)

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium
Contributors: Katharina Beyer, Renée Leenen, Lionne Venderbos, Jozien Helleman, Frederique Denijs, Wichor Bramer, Vera Vasilyeva, Erik Briers, Juan Gómez Rivas, Renata Chloupkova et al.
Journal: Journal of Personalized Medicine (2024)

Navigating Through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs
Contributors: Juan Gómez Rivas, Renée C. A. Leenen, Lionne Venderbos, Jozien Helleman, Irene de la Parra, Vera Vasilyeva, Moreno-Sierra J., Partha Basu, Arunah Chandran, Roderick C. N. van den Bergh et al.
Journal: Journal of Personalized Medicine (2023)

European Cancer Organisation’s Inequalities Network: Putting Cancer Inequalities on the European Policy Map
Contributors: Hendrik Van Poppel, Nicolò M. L. Battisti, Mark Lawler, Teodora Kolarova, Jacqueline Daly, Katie Rizvi, Robert Greene, Guy Buyens, Kathy Oliver, Richard Price et al.
Journal: JCO Global Oncology (2022)

Serum PSA-Based Early Detection of Prostate Cancer in Europe and Globally: Past, Present and Future
Contributors: Hendrik Van Poppel, Tit Albreht, Partha Basu, Renée Hogenhout, Sarah Collen, Monique Roobol
Journal: Nature Reviews Urology (2022)

Dr Eun-Gyung Cho | Biomaterials | Best Researcher Award

Published on 03/06/2025 by Material Scientist

Dr Eun-Gyung Cho | Biomaterials | Best Researcher Award

Dr. Eun-Gyung Cho is a leading biomedical scientist specializing in extracellular vesicles (EVs), skin biology, and stem cell applications. She currently holds multiple leadership positions, including Director of the H&B Science Center at CHA Meditech Co., Ltd., Director of the Consumer Health 2 Center at CHA Advanced Research Institute, and Adjunct Associate Professor at CHA University. Her career bridges cutting-edge biomedical research with real-world therapeutic and cosmetic applications, particularly in skin regeneration, aging, and immunology. She has published over 50 scientific papers and filed more than 240 patents, demonstrating innovation and scientific excellence across academia and industry.

Dr Eun-Gyung Cho, CHA R&D Institute/CHABio group, South Korea

Profile

ORCID

SCOPUS

🎓 Education

Dr. Eun-Gyung Cho holds a strong academic foundation in biological sciences and biotechnology. She earned her Ph.D. in Biological Sciences from Seoul National University (1998–2002) 🧬🎓, where she specialized in molecular and cellular biology. Prior to that, she completed her M.S. in Life Science at GIST, Kwangju (1996–1998) 🔬📘, gaining expertise in bio-research and developmental biology. Her academic journey began with a B.S. in Agricultural Biology at Seoul National University (1992–1996) 🌱🧪, where she built her initial skills in genetics, plant science, and biotechnology. This educational pathway laid the groundwork for her exceptional career in biomedical innovation.

🏢 Professional Experience

Dr. Eun-Gyung Cho brings over two decades of dynamic experience across academia, research, and biotechnology innovation. She currently serves as Director at CHA Meditech and the CHA Advanced Research Institute, and is an Adjunct Associate Professor at CHA University 🏢🔬📚. Previously, she held senior leadership roles at Amorepacific Corporation, including Team Leader and Chief Scientist, where she led R&D in bio-cosmeceuticals and exosome-based technologies 💄🧫. Her global expertise is further enriched by postdoctoral research at the NIH and Sanford-Burnham Institute in the USA 🌍🧠. Dr. Cho’s career reflects a blend of scientific depth, leadership, and innovation 💡🧪.

🧖‍♀️ Research Experience

Dr. Eun-Gyung Cho has led a distinguished research career in extracellular vesicles (EVs), stem cell biology, and skin science across academia and industry. At CHA Meditech and Amorepacific, she developed innovative biomaterials including EV-based skin boosters, anti-aging formulations, and microbial-derived therapies 🧪🧖‍♀️🌿. Her postdoctoral work at Sanford-Burnham and NIH advanced neurogenesis, cell cycle regulation, and bio-signaling mechanisms 🧠🔬🧫. With over 240 patents and 40+ publications, she has made pioneering contributions in cosmeceuticals, dermaceuticals, and regenerative medicine 🌟📈💊. Her research bridges fundamental science with real-world applications in skin health and personalized biotherapy.

🔬 Research Focus

Dr. Eun-Gyung Cho’s research centers on extracellular vesicles (EVs) 🧫, particularly their roles in intercellular communication, drug delivery, and as biomaterials for dermatological therapy 💉🧴. She specializes in developing skin boosters and biostimulators using EVs, peptides, recombinant proteins, and stem cell-conditioned media 🧬. Her work extends to skin biology 🧖‍♀️—exploring melanogenesis, skin barrier function, and cutaneous immunity—and stem cell biology, including iPSC differentiation into skin and neural lineages 🌱🧠. With deep roots in molecular biology, she also investigates cell cycle regulation, tumorigenesis, and apoptosis, bridging fundamental science with regenerative and aesthetic medicine 🧪💡.

📚 Publications

Human Probiotic Lactobacillus paracasei-Derived Extracellular Vesicles Improve Tumor Necrosis Factor-α-Induced Inflammatory Phenotypes in Human Skin
Authors: Kwang-soo Lee, Yunsik Kim, Jin Hee Lee, Suji Shon, Aram Kim, An Vuong Quynh Pham, Chungho Kim, Dong Hyun Kim, Yoon-Keun Kim, Eun-Gyung Cho
Journal: Cells, 2023

Comparative Lipidomic Analysis of Extracellular Vesicles Derived from Lactobacillus plantarum APsulloc 331261 Living in Green Tea Leaves Using Liquid Chromatography-Mass Spectrometry
Authors: Hyoseon Kim, Minjung Kim, Kilsun Myoung, Wanil Kim, Jaeyoung Ko, Kwang Pyo Kim, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2020

Kojyl Cinnamate Ester Derivatives Increase Adiponectin Expression and Stimulate Adiponectin-Induced Hair Growth Factors in Human Dermal Papilla Cells
Authors: Phil June Park, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2019

Circadian Expression of TIMP3 Is Disrupted by UVB Irradiation and Recovered by Green Tea Extracts
Authors: Sunyoung Park, Eun-Soo Lee, Nok-Hyun Park, Kyeonghwan Hwang, Eun-Gyung Cho
Journal: International Journal of Molecular Sciences, 2019

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Published on 30/05/2025 by Material Scientist

Prof. Dr Yuan Xu | Biomaterials | Best Researcher Award

Prof. Dr. Yuan Xu is a renowned physician-scientist and Chief Physician at the China-Japan Friendship Hospital 🏥. Holding both an MD and PhD, he specializes in the integration of Traditional Chinese Medicine (TCM) and Western medicine 🔬🌱. He serves as Deputy Director of the National Center for Integrated Medicine and is a Master’s Supervisor guiding future clinicians 🎓🧑‍⚕️. As a former visiting scholar at Yale University, his global outlook informs research on rheumatology, fibromyalgia, and chronic disease care 🌍💡. With 48 publications, 12 SCI papers, and multiple funded projects, he is a leader in translational healthcare innovation 🧠🏆.

Prof. Dr Yuan Xu, China-Japan Friendship Hospital, China

Profile

SCOPUS

Education 🎓

Prof. Dr. Yuan Xu holds both an MD and a PhD, establishing a strong foundation in clinical medicine and biomedical research 🩺🔬. His dual training bridges Western medical science and Traditional Chinese Medicine (TCM), enabling an integrative approach to healthcare 🌍🌱. He further enriched his academic profile as a visiting scholar at Yale University, USA, where he engaged in global research collaboration and advanced clinical studies 🇺🇸📖. This diverse educational background equips him with a comprehensive and holistic view of medicine, fueling his innovative work in rheumatology and chronic disease treatment 💡🧠.

Experience 🏥

Prof. Dr. Yuan Xu is a seasoned Chief Physician at the China-Japan Friendship Hospital and serves as a Master’s Supervisor, nurturing the next generation of clinicians and researchers 🎓👨‍🏫. As Deputy Director at the National Center for Integrated Traditional Chinese and Western Medicine, he leads national initiatives merging TCM with modern medical science ⚕️🌿. Recognized as an Innovative Young Talent and a “New 125” TCM Leader, he also gained international exposure as a visiting scholar at Yale University 🌍📚. His career spans clinical care, policy leadership, and translational research in chronic disease management 🧠🦴.

Contributions 📖

Prof. Dr. Yuan Xu has made impactful contributions in three core research areas: the development of diagnostic and treatment protocols for rheumatoid arthritis using Traditional Chinese Medicine (TCM) 🌿🦴, the advancement of fibromyalgia care strategies 🧠💊, and the management of integrated TCM and Western medical systems 🏥⚖️. He has led 12 major research projects, securing over 10 million yuan in funding 💰📊. His academic output includes 48 publications, with 12 SCI-indexed papers, where he served as first or corresponding author ✍️🔍. His work bridges clinical care and scientific discovery in modern integrative medicine 🧬🩺.

Research Focus 🔬

Prof. Dr. Yuan Xu’s research primarily targets rheumatoid diseases, with a strong emphasis on rheumatoid arthritis and fibromyalgia syndrome 🦴🧬. His work integrates Traditional Chinese Medicine (TCM) and modern biomedical approaches to develop more effective diagnostic models and personalized treatments 🌱⚕️. He investigates immune system dysregulation, inflammatory pathways, and syndrome differentiation in chronic joint disorders 🔍💊. Through national and international collaborations, including with Yale University, he bridges ancient practices with advanced clinical research 🏥🌍. His translational focus ensures that findings directly improve patient outcomes in chronic rheumatologic care 📈🧑‍⚕️.

Publications 📚

Early prediction of bone destruction in rheumatoid arthritis through machine learning analysis of plasma metabolites
Authors: Wang Zihan, Lan Tianyi, Jiao Yi, Tao Qingwen, Xu Yuan
Journal: Arthritis Research and Therapy, 2025 🧠💉📊

Clinical Characteristics and Influencing Factors of Rheumatoid Arthritis in Patients with Cold Dampness Obstruction Syndrome
Authors: Chen Yanyu, Li Yanqi, Liu Longxiao, Xu Yuan, Tao Qingwen
Journal: Chinese Journal of Experimental Traditional Medical Formulae, 2025 🌿🦴📘

Integrated phytochemistry and network pharmacology analysis to reveal effective substances and mechanisms of Bushen Quhan Zhiwang decoction in the treatment of rheumatoid arthritis
Authors: Zhang Liubo, Yan Yu, Ma Ru, Tao Qingwen, Xu Yuan
Journal: Journal of Ethnopharmacology, 2024 🌱⚗️🔎